JSPR logo

Jasper Therapeutics (JSPR) EBITDA

Annual EBITDA

-$74.87 M
-$7.11 M-10.50%

December 31, 2024


Summary


Performance

JSPR EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJSPRprofitabilitymetrics:

Quarterly EBITDA

-$25.04 M
-$5.69 M-29.42%

December 31, 2024


Summary


Performance

JSPR Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJSPRprofitabilitymetrics:

TTM EBITDA

-$74.87 M
-$7.60 M-11.30%

December 31, 2024


Summary


Performance

JSPR TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherJSPRprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

JSPR EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-10.5%-29.4%-11.3%
3 y3 years-105.4%-31.2%-17.4%
5 y5 years-262.0%-31.2%-17.4%

JSPR EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-105.4%at low-113.2%at low-127.2%at low
5 y5-year-262.0%at low-2863.8%at low-663.3%at low
alltimeall time-262.0%at low-2863.8%at low-663.3%at low

Jasper Therapeutics EBITDA History

DateAnnualQuarterlyTTM
Dec 2024
-$74.87 M(+10.5%)
-$25.04 M(+29.4%)
-$74.87 M(+11.3%)
Sep 2024
-
-$19.35 M(+23.3%)
-$67.27 M(+0.4%)
Jun 2024
-
-$15.69 M(+6.2%)
-$67.01 M(-2.7%)
Mar 2024
-
-$14.78 M(-15.2%)
-$68.86 M(+1.6%)
Dec 2023
-$67.75 M(+34.9%)
-$17.44 M(-8.6%)
-$67.75 M(+6.2%)
Sep 2023
-
-$19.09 M(+8.7%)
-$63.78 M(+11.6%)
Jun 2023
-
-$17.55 M(+28.4%)
-$57.14 M(+11.3%)
Mar 2023
-
-$13.67 M(+1.5%)
-$51.33 M(+2.2%)
Dec 2022
-$50.22 M
-$13.47 M(+8.3%)
-$50.22 M(-3.1%)
DateAnnualQuarterlyTTM
Sep 2022
-
-$12.44 M(+5.9%)
-$51.81 M(+21.5%)
Jun 2022
-
-$11.74 M(-6.5%)
-$42.64 M(+8.5%)
Mar 2022
-
-$12.56 M(-16.6%)
-$39.28 M(+19.2%)
Dec 2021
-$36.46 M(+76.3%)
-$15.06 M(+360.5%)
-$32.95 M(+94.0%)
Sep 2021
-
-$3.27 M(-61.0%)
-$16.99 M(-30.5%)
Jun 2021
-
-$8.39 M(+34.6%)
-$24.43 M(+52.3%)
Mar 2021
-
-$6.23 M(-787.9%)
-$16.04 M(+63.5%)
Dec 2020
-$20.68 M
$906.00 K(-108.5%)
-$9.81 M(-8.5%)
Sep 2020
-
-$10.71 M
-$10.71 M

FAQ

  • What is Jasper Therapeutics annual EBITDA?
  • What is the all time high annual EBITDA for Jasper Therapeutics?
  • What is Jasper Therapeutics annual EBITDA year-on-year change?
  • What is Jasper Therapeutics quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Jasper Therapeutics?
  • What is Jasper Therapeutics quarterly EBITDA year-on-year change?
  • What is Jasper Therapeutics TTM EBITDA?
  • What is the all time high TTM EBITDA for Jasper Therapeutics?
  • What is Jasper Therapeutics TTM EBITDA year-on-year change?

What is Jasper Therapeutics annual EBITDA?

The current annual EBITDA of JSPR is -$74.87 M

What is the all time high annual EBITDA for Jasper Therapeutics?

Jasper Therapeutics all-time high annual EBITDA is -$20.68 M

What is Jasper Therapeutics annual EBITDA year-on-year change?

Over the past year, JSPR annual EBITDA has changed by -$7.11 M (-10.50%)

What is Jasper Therapeutics quarterly EBITDA?

The current quarterly EBITDA of JSPR is -$25.04 M

What is the all time high quarterly EBITDA for Jasper Therapeutics?

Jasper Therapeutics all-time high quarterly EBITDA is $906.00 K

What is Jasper Therapeutics quarterly EBITDA year-on-year change?

Over the past year, JSPR quarterly EBITDA has changed by -$5.69 M (-29.42%)

What is Jasper Therapeutics TTM EBITDA?

The current TTM EBITDA of JSPR is -$74.87 M

What is the all time high TTM EBITDA for Jasper Therapeutics?

Jasper Therapeutics all-time high TTM EBITDA is -$9.81 M

What is Jasper Therapeutics TTM EBITDA year-on-year change?

Over the past year, JSPR TTM EBITDA has changed by -$7.60 M (-11.30%)